Inhibition of HDACs-EphA2 Signaling Axis with WW437 Demonstrates Promising Preclinical Antitumor Activity in Breast Cancer.
about
Inhibition of HDACs-EphA2 Signaling Axis with WW437 Demonstrates Promising Preclinical Antitumor Activity in Breast Cancer.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Inhibition of HDACs-EphA2 Sign ...... mor Activity in Breast Cancer.
@en
Inhibition of HDACs-EphA2 Sign ...... mor Activity in Breast Cancer.
@nl
type
label
Inhibition of HDACs-EphA2 Sign ...... mor Activity in Breast Cancer.
@en
Inhibition of HDACs-EphA2 Sign ...... mor Activity in Breast Cancer.
@nl
prefLabel
Inhibition of HDACs-EphA2 Sign ...... mor Activity in Breast Cancer.
@en
Inhibition of HDACs-EphA2 Sign ...... mor Activity in Breast Cancer.
@nl
P2093
P2860
P1433
P1476
Inhibition of HDACs-EphA2 Sign ...... umor Activity in Breast Cancer
@en
P2093
Feifei Yang
Jingjie Li
Mingyao Liu
Wangrui Jin
Xiaojun Ma
Yingqi Hua
P2860
P304
P356
10.1016/J.EBIOM.2018.05.003
P50
P577
2018-05-01T00:00:00Z